The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion
Open accessAbstract
The effects of nonpromoting and weakly promoting diterpenes on skin tumor promotion by 12- O -tetradecanoylphorbol 13-acetate (TPA) were investigated. When phorbol and phorbol 12,13-diacetate (both nonpromoting) were given simultaneously with TPA after 7,12-dimethylbenz[ a ]-anthracene (DMBA) initiation in female mice, they had no effect on TPA promotion. However, the nonpromoter 4- O -methyl-TPA and the weak promoter mezerein were found to inhibit TPA promotion in a dose-dependent manner when given simultaneously with TPA. Because mezerein was found to be an effective inhibitor of TPA promotion when given simultaneously and because it induces many biological responses similar to those to TPA, the capacity of mezerein to act as an incomplete promoter in a two-stage promotion protocol was also investigated. Twice-weekly applications of 1,2, or 5 μg of TPA for 2 weeks after DMBA initiation produced 0, 0, and 0.5 papilloma per mouse, respectively, at 20 weeks. When the twice-weekly applications of TPA for 2 weeks were followed by twice-weekly treatments with 2 μg of mezerein for 18 weeks, the number of papillomas per mouse was 2.2, 3.5, and 9.0, respectively. Twice-weekly applications of 2 μg of TPA for 2 weeks followed by twice-weekly treatments with 1, 2, or 4 μg of mezerein for 18 weeks produced 2.1, 3.5, and 6.8 papillomas per mouse, respectively, in DMBA-treated mice. Twice-weekly doses as high as 40 μg of 4- O -methyl-TPA were not effective in producing tumors when given after a limited treatment with TPA; however, 4- O -methyl-TPA had weak activity as a first-stage promoter. The results suggest that although mezerein by itself is a weak promoter and mimics TPA in many biochemical and morphological effects it is a potent second-stage promoter in a two-stage promotion regimen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some Biological Aspects of Skin Carcinogenesis*
Boutwell, R. K. (2015) · Progress in Tumor Research · doi:10.1159/000385978 · Cited by 623
Shoyab, M., De Larco, J. E., & Todaro, G. J. (1979) · Nature · doi:10.1038/279387a0 · Cited by 504
Huberman, E., & Callaham, M. F. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1293 · Cited by 500
Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents.
O’Brien, T. G., Simsiman, R. C., & Boutwell, R. K. (1975) · PubMed · Cited by 495
Tumor-Promoting Phorbol Esters Inhibit Binding of Epidermal Growth Factor to Cellular Receptors
Lee, L., & Weinstein, I. B. (1978) · Science · doi:10.1126/science.308698 · Cited by 349
Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells.
Mondal, S., Brankow, D. W., & Heidelberger, C. (1976) · PubMed · Cited by 291
Effect of a tumour promoter on myogenesis
Cohen, R. M., Pacifici, M., Rubinstein, N. A., Biehl, J., & Holtzer, H. (1977) · Nature · doi:10.1038/266538a0 · Cited by 255
YUSPA, S. H., LICHTI, U., BEN, T., PATTERSON, E., HENNINGS, H., SLAGA, T. J., COLBURN, N., & KELSEY, W. (1976) · Nature · doi:10.1038/262402a0 · Cited by 245
Self-citationRaick, A. N. (1973) · PubMed · Cited by 194
Huberman, E., Heckman, C. A., & Langenbach, R. J. (1979) · PubMed · Cited by 177
Mufson, R. A., Sm, F., Verma, A. K., Gleason, G. L., Slaga, T. J., & Boutwell, R. K. (1979) · PubMed · Cited by 132
Self-citationThe stimulation of phospholipid metabolism in mouse skin following phorbol ester treatment
Rohrschneider, L. R., O'Brien, D., & Boutwell, R. K. (1972) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(72)90212-3 · Cited by 109
Slaga, T. J., Bowden, G. T., & Boutwell, R. K. (1975) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/55.4.983 · Cited by 71
Self-citationTumour promoter TPA enhances transformation of human leukocytes by Epstein–Barr virus
Yamamoto, N., & Hausen, H. Z. (1979) · Nature · doi:10.1038/280244a0 · Cited by 69
Effects of a tumor‐promoting agent on chondrogenesis
Pacifici, M., & Holtzer, H. (1977) · American Journal of Anatomy · doi:10.1002/aja.1001500116 · Cited by 66
Raick, A. N., & Burdzy, K. (1973) · PubMed · Cited by 50
Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters.
Mondal, S., & Heidelberger, C. (1980) · PubMed · Cited by 32
Cited by
Prooxidant States and Tumor Promotion
Cerutti, P. A. (1985) · Science · doi:10.1126/science.2981433 · Cited by 2,497
Free Radicals as Mediators of Tissue Injury and Disease
Kehrer, J. P. (1993) · Critical Reviews in Toxicology · doi:10.3109/10408449309104073 · Cited by 1,455
13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia
Hong, W. K., Endicott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152401 · Cited by 819
Multistage carcinogenesis in mouse skin
DiGiovanni, J. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90051-z · Cited by 642
Carcinogen-mediated oxidant formation and oxidative DNA damage
Frenkel, K. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90047-4 · Cited by 379
Metadata
- Authors
- Slaga, T. J., Fischer, S. M., Nelson, K., & Gleason, G. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1980-06
- Volume
- 77
- Issue
- 6
- Pages
- 3659-3663
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1986270436
- Cited by
- 331
- References
- 17
- FWCI
- 15.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.